ASSESSMENT OF THE QUALITY OF LIFE OF PATIENTS WITH TYPE 2 DIABETES COMPLICATED BY DIABETIC PERIPHERAL POLYNEUROPATHY ON THE BACKGROUND OF REDUCED CONTENT VITAMIN D3 IN THE BLOOD
DOI:
https://doi.org/10.11603/2411-1597.2023.3-4.14238Keywords:
diabetes, neuropathic pain, quality of life, vitamin D3Abstract
Introduction. Today, diabetes has reached the scale of a serious epidemic, which is growing rapidly. In 2021, the total number of people with diabetes was 537 million, and by 2045, more than 783 million are expected. This disease is often accompanied by diabetic peripheral polyneuropathy, in particular, in 70 % of people, 15 % of them have neuropathic pain, which significantly affects the quality of life. Studies also show a link between vitamin D3 deficiency and the risk of developing diabetes and diabetic peripheral neuropathy.
The aim of the study – to assess the quality of life of patients with type 2 diabetes complicated by diabetic peripheral polyneuropathy against the background of reduced vitamin D3 content in the blood.
The main part. The EuroQol-5D-5L questionnaire was used to assess the quality of life of 66 type 2 diabetes patients with existing neuropathic pain depending on the level of 25(OH)D in the blood. It was established that in these patients the deficiency of vitamin D3 prevailed over its insufficiency. According to the results of the survey, patients demonstrated moderate problems with walking, minor or moderate problems with independent washing and dressing, moderate difficulties in performing normal daily tasks, more than half of the surveyed patients were concerned about the presence of severe pain or discomfort, and moderate - almost all patients who remained, while the majority of patients noted slight or moderate anxiety or depression.
Conclusions. Survey results for patients with diabetes mellitus and diabetic peripheral neuropathy indicate moderate problems with walking, minor or moderate problems with independent bathing and dressing, and moderate difficulties with normal activities of daily living. Patients experience mild to moderate anxiety or depression and significant to moderate discomfort. Vitamin D3 deficiency was found in patients, which requires control of its level for adequate correction with the help of non-drug and drug measures.
References
IDF Diabetes Atlas, 10th edition. (2021). [Electronic resource]. Retrieved from: https://diabetesatlas.org/data/en/country/207/ua.html.
Pankiv, V.I. (2013). Tsukrovyi diabet: vyznachennia, klasyfikatsiia, epidemiolohiia, faktory ryzyku [Sugar diabetes: definition, classification, epidemiology, risk factors]. Mizhnarodnyy endokrynolohichnyy zhurnal – International Journal of Endocrinology, 7.55, 95–104. DOI: 10.22141/2224-0721.7.55.2013.84685 [in Ukrainian]. DOI: https://doi.org/10.22141/2224-0721.7.55.2013.84685
Basem, J.I., Bah, F.N., & Mehta, N.D. (2023). A Brief Review on the Novel Therapies for Painful Diabetic Neuropathy. Current Pain and Headache Reports. DOI: 10.1007/s11916-023-01126-1. DOI: https://doi.org/10.1007/s11916-023-01126-1
Lezhenko, H. O., & Pashkova, O.Ie. (2009). Diabetychna neiropatiia: pohliad na problemu ta mozhlyvi shliakhy yii rozviazannia [Diabetic neuropathy: a view of the problem and possible solutions]. Dyt. likar. – Child doctor., 1, 42-54 [in Ukrainian].
Huizinga, M.M., & Peltier, A. (2007). Painful Diabetic Neuropathy: A Management-Centered Review. Clinical Diabetes, 25(1), 6-15. DOI: 10.2337/diaclin.25.1.6. DOI: https://doi.org/10.2337/diaclin.25.1.6
Yu, Y. (2021). Gold Standard for Diagnosis of DPN. Frontiers in Endocrinology, 12. DOI: 10.3389/fendo.2021.719356. DOI: https://doi.org/10.3389/fendo.2021.719356
Makarchuk, N.R. (2018). Dn4 questionnaire in family practice for evaluation of clinical manifestations of neuropathic pain in type 2 diabetes patients treated by light therapy. International Journal of Medicine and Medical Research, 1. DOI: 10.11603/ijmmr.2413-6077.2018.1.8717. DOI: https://doi.org/10.11603/ijmmr.2413-6077.2018.1.8717
Song, Y. (2013). Blood 25-Hydroxy Vitamin D Levels and Incident Type 2 Diabetes: A meta-analysis of prospective studies. Diabetes Care, 36(5), 1422-1428. DOI: 10.2337/dc12-0962. DOI: https://doi.org/10.2337/dc12-0962
Shen, L., Zhuang, Q.-S., & Ji, H.-F. (2016). Assessment of vitamin D levels in type 1 and type 2 diabetes patients: Results from meta-analysis. Molecular Nutrition & Food Research, 60(5), 1059-1067. DOI: 10.1002/mnfr.201500937. DOI: https://doi.org/10.1002/mnfr.201500937
Shehab, D. (2015). Prospective Evaluation of the Effect of Short-Term Oral Vitamin D Supplementation on Peripheral Neuropathy in Type 2 Diabetes Mellitus. Medical Principles and Practice, 24(3), 250-256. DOI: 10.1159/000375304. DOI: https://doi.org/10.1159/000375304
Ghadiri-Anari, A. (2019). Prediabetes and gastrointestinal (GI) symptoms; a cross-sectional study. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 13(1), 844-846. DOI: 10.1016/j.dsx.2018.12.005. DOI: https://doi.org/10.1016/j.dsx.2018.12.005
Povoroznyuk, V.V., & Balatska, N.I. (2013). Defitsyt vitaminu D u naselennia Ukrainy ta faktory ryzyku yoho rozvytku [Vitamin D deficiency in the population of Ukraine and risk factors for its development]. Bil, suhloby, khrebet – Pain, joints, spine, 4.08, 5-11. DOI: 10.22141/2224-1507.0.04.08.2012.82908 [in Ukrainian]. DOI: https://doi.org/10.22141/2224-1507.0.04.08.2012.82908
Tovstolytkina, N. (2019). Vitamin D – is everything as simple as it seems? Mizhnarodnyy endokrynolohichnyy zhurnal – International Journal of Endocrinology, 15(4), 334-338. DOI: 10.22141/2224-0721.15.4.2019.174821. DOI: https://doi.org/10.22141/2224-0721.15.4.2019.174821
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Nursing
This work is licensed under a Creative Commons Attribution 4.0 International License.
